表纸
市场调查报告书

单次使用生物反应器市场:成长、动向、预测(2020年~2025年)

Single-use Bioreactor Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品编码 941576
出版日期 内容资讯 英文
商品交期: 2-3个工作天内
价格
单次使用生物反应器市场:成长、动向、预测(2020年~2025年) Single-use Bioreactor Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年06月10日内容资讯: 英文
简介

市场以、制品种类(单次使用生物反应器系统、媒体袋、过滤组件、其他制品)、细胞种类(哺乳类细胞、细菌、酵母、其他细胞种类)、分子种类、终端使用者、地域为基础进行分割。

市场概要

全球单次使用生物反应器市场,预测期间中预定为15.5%的CAGR。市场的成长要因,包括业界single-use technologies(SUT)的迅速采用、性价比与停机时间的缩短、新制品的发售等。

业界对于单次使用生物反应器使用的倾向,现在被步驟的重要性、制品的价值、及制品的开发与生产时间所影响。这些单次使用生物反应器在医疗领域的需求很高。因此,这些反应炉被制药公司所采用制造医药品,无需对其品质进行任何协商。采用单次使用生物反应器最大优点之一为其弹性。因多剂型施设发展的倾向较强,在同一施设使用,以最短的时间最少的成本生产不同的医药品是所追求的目标。

但是,在某个时间点,塑胶制品及单品的消耗品重复成本使得设备投资额上升。固定不锈钢机器,在设置及维持管理面上初期费用虽然较高,可知单次使用生物反应器(SUB)的定期的经费变高。另外,为了妥善处理大量不用品,也需要花费高昂成本。

调查范围

单次使用生物反应器,现在已是生物科技制造施设不可缺的部分。制造技术上延续的制品革新与研究开发费的增加,改善了全体排程,为提供高品质的制品,有主要推进力的机能。因此,从不锈钢生物反应器转变为单次使用生物反应器变得容易许多。单次使用生物反应器,比较安全、简单、有弹性。也因此,使用增加了。

本报告中,调查了单次使用生物反应器的全球市场,并提供市场概要、制品种类别□细胞种类别□分子种类别□终端使用者别□地域别的市场动向、市场规模的转变与预测、市场促进□阻碍要因及市场机会的分析、市场占有、竞争情势、主要企业档案资料等等情报。

目次

第1章 导论

  • 调查成果
  • 调查的前提条件
  • 调查范围

第2章 调查手法

第3章 执行摘要

第4章 市场力学

  • 市场概要
  • 市场成长要因
    • 业界别single-use technologies (SUT)的迅速采用
    • 性价比与停机时间的缩短
    • 新制品的发售
  • 市场的阻碍要因
    • 高昂的经常性费用
    • 满足适合制造基准的基准问题
  • 波特五力分析

第5章 市场细分化

  • 制品种类别
    • 单次使用生物反应器系统
    • 媒体袋
    • 过滤组件
    • 其他制品
  • 细胞种类别
    • 哺乳动物细胞
    • 细菌
    • 酵母
    • 其他的细胞型
  • 分子种类别
    • 疫苗
    • 单株抗体
    • 干细胞
    • 遗传重组蛋白质
    • 其他的分子种类
  • 终端使用者别
    • 制药及生物技术医药品产业
    • 受托调查机关(CRO)
    • 其他终端使用者
  • 地域别
    • 北美
    • 欧洲
    • 亚洲太平洋
    • 中东□非洲
    • 南美

第6章 竞争情势

  • 企业档案
    • ABEC Inc.
    • Celltainer
    • Distek Inc.
    • Eppendorf AG
    • GE Healthcare
    • Merck KGaA
    • OmniBRx Biotechnologies
    • Pall Corporation
    • Sartorius AG
    • Thermo Fisher Scientific
目录

The Market is Segmented on the basis of Type of Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), Molecule Type, End User, and Geography.

Market Overview

The global single-use bioreactor market is expected to witness a CAGR of 15.5% during the forecast period. Certain factors that are driving the market's growth include rapid adoption of single-use technologies (SUTs) by the industry, cost-effectiveness and lower downtime, and launch of new products.

The inclination of the industry toward using single use bioreactors is currently being influenced by the criticality of the step, the value of the product, and the time for product development and production. These single-use bioreactors are in high demand, from the medical sector. These reactors are thus adopted by the pharmaceutical, companies to manufacture drugs without any negotiations on their quality. One of the biggest advantages of the adoption of single use bioreactors is the flexibility. The increasing trend toward multi drug facilities demands the production of different drugs, using the same facility, in minimum time and with minimum costs.

However, at some point, the capital investment is found to be exceeded by the repetitive cost for plasticware and single-use consumables. So, although fixed stainless steel equipment have high upfront costs in terms of installation and maintenance, the regular recurring expenses for single-use bioreactors (SUBs) is found to be higher. In addition, high costs may be involved in proper waste management of the vast amounts of disposables.

Scope of the Report

Single-use bioreactors, also known as disposable bioreactors, have now become an integral part of the biotechnology manufacturing facilities. Continuous product innovation and increasing R&D expenditure in manufacturing technology act as key drivers in improving the overall process and providing high-quality products. This facilitates the transition from stainless steel bioreactors to single-use bioreactors. Single-use bioreactors are comparatively safe, simple, and flexible. Thus, their usage is increasing.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Adoption of Single-use Technologies (SUTs) by the Industry
    • 4.2.2 Cost Effectiveness and Lower Downtime
    • 4.2.3 Launch of New Products
  • 4.3 Market Restraints
    • 4.3.1 High Regular Recurring Expenses
    • 4.3.2 Issues with Meeting the Standards of Good Manufacturing Practices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Type of Product
    • 5.1.1 Single-use Bioreactor Systems
    • 5.1.2 Media Bags
    • 5.1.3 Filtration Assemblies
    • 5.1.4 Other Products
  • 5.2 Cell Type
    • 5.2.1 Mammalian Cell
    • 5.2.2 Bacteria
    • 5.2.3 Yeast
    • 5.2.4 Other Cell Types
  • 5.3 Molecule Type
    • 5.3.1 Vaccines
    • 5.3.2 Monoclonal Antibodies
    • 5.3.3 Stem Cells
    • 5.3.4 Recombinant Proteins
    • 5.3.5 Other Molecule Types
  • 5.4 End User
    • 5.4.1 Pharmaceutical and Biopharmaceutical Industries
    • 5.4.2 Contract Research Organizations (CRO)
    • 5.4.3 Other End Users
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East & Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ABEC Inc.
    • 6.1.2 Celltainer
    • 6.1.3 Distek Inc.
    • 6.1.4 Eppendorf AG
    • 6.1.5 GE Healthcare
    • 6.1.6 Merck KGaA
    • 6.1.7 OmniBRx Biotechnologies
    • 6.1.8 Pall Corporation
    • 6.1.9 Sartorius AG
    • 6.1.10 Thermo Fisher Scientific